| This article has been cited by |
| 1 | Deflazacort-induced Acneiform Eruptions | |
| Mohammed ShakeelMohammed Bashir,Mohammad Saleem,Uday Choudhari |
| Journal of Pharmacy And Bioallied Sciences.2017;9(4)284 |
| [DOI] |
|
| 2 | Dissolution enhancement of Deflazacort using hollow crystals prepared by antisolvent crystallization process | |
| A.S. Paulino,G. Rauber,C.E.M. Campos,M.H.P. Maurício,R.R. de Avillez,G. Capobianco,S.G. Cardoso,S.L. Cuffini |
| European Journal of Pharmaceutical Sciences.2013;49(2)294 |
| [DOI] |
|
| 3 | Basics of bone metabolism and osteoporosis in common pediatric neuromuscular disabilities | |
| Evren Yasar,Emre Adigüzel,Mutluay Arslan,Dennis J. Matthews |
| European Journal of Paediatric Neurology.2018;22(1)17 |
| [DOI] |
|
| 4 | Lichen Planus in Childhood: A Series of 316 Patients | |
| Deepika Pandhi,Archana Singal,Sambit N. Bhattacharya |
| Pediatric Dermatology.2014;31(1)59 |
| [DOI] |
|
| 5 | Metabolic considerations of drugs in the treatment of allergic diseases | |
| Elena García-Martín,Gabriela Canto,José AG Agúndez |
| Expert Opinion on Drug Metabolism & Toxicology.2013;9(11)1437 |
| [DOI] |
|
| 6 | Response Surface Optimization of Ultra-Elastic Nanovesicles Loaded with Deflazacort Tailored for Transdermal Delivery: Accentuated Bioavailability and Anti-Inflammatory Efficacy | |
| Adel A Ali,Amira H Hassan,Essam M Eissa,Heba M Aboud |
| International Journal of Nanomedicine.2021;Volume 16(11)591 |
| [DOI] |
|
| 7 | Hazard and health risk assessment of exposure to pharmaceutical active compounds via toxicological evaluation by zebrafish | |
| Imen Ben Chabchoubi,Su Shiung Lam,Stacey Ellen Pane,Mohamed Ksibi,Giulia Guerriero,Olfa Hentati |
| Environmental Pollution.2023;324(11)120698 |
| [DOI] |
|
| 8 | Hazard and health risk assessment of exposure to pharmaceutical active compounds via toxicological evaluation by zebrafish | |
| Ross E. Petty |
| Environmental Pollution.2015;324(11)11 |
| [DOI] |
|
| 9 | Three Cases of Erythema Multiforme Developed during Deflazacort Therapy in Children with Nephrotic Syndrome | |
| Seung Jin Lee,Bong Hwa Kang,Min Hyun Cho |
| Journal of the Korean Society of Pediatric Nephrology.2014;18(2)123 |
| [DOI] |
|
| 10 | A review of nosocomial Salmonella outbreaks: infection control interventions found effective | |
| M.B. Lee,J.D. Greig |
| Public Health.2013;127(3)199 |
| [DOI] |
|
| 11 | Isolation and structural characterization of novel photolytic degradation impurities of Deflazacort using Q-TOF, 2D-NMR and FTIR | |
| Ch Krishnam Raju,Avadhesh Kumar Pandey,Kaushik Ghosh,Arunima Pola,Sanath Kumar Goud,Mrunal A. Jaywant,Sameer G. Navalgund,Koduru V. Surendranath |
| Journal of Pharmaceutical and Biomedical Analysis.2017;133(3)82 |
| [DOI] |
|
| 12 | ???????????? 1-(4-Cl-??????)-3-Cl-4-(CF3-??????????)- 1?-?????-2,5-????? ?? ??????????????? ?????????? ???????????? ??? ??????????? ?????????????? ?????????? ?? ??? ?????????????????? ?????????? ????????? ? ????? | |
| ?.?. ?????????,?.?. ?????????,?.?. ????????,?.?. ?????,?.?. ???????,?.?. ????,?.?. ??????????? |
| Reports of the National Academy of Sciences of Ukraine.2021;133(4)94 |
| [DOI] |
|
| 13 | Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis | |
| A. Kavanaugh,A. F. Wells |
| Rheumatology.2014;53(10)1742 |
| [DOI] |
|
| 14 | Preparation and characterization of polymorphs of the glucocorticoid deflazacort | |
| Diego E. Kassuha,Virginia Aiassa,Flavia P. Bruno,Gabriel Cuadra,Norma R. Sperandeo |
| Pharmaceutical Development and Technology.2015;20(4)401 |
| [DOI] |
|
| 15 | Aktueller Stand der oralen Therapie mit immunmodulatorischen und immunsuppressiven Medikamenten | |
| S. Meller,A.M. Baran,S.A. Braun,N. Klossowski,B. Homey |
| Der Hautarzt.2014;65(2)89 |
| [DOI] |
|
| 16 | Acute and chronic corticosteroid treatment of ten patients with paralytic form of Sydenham’s chorea | |
| Carlo Fusco,Valentina Ucchino,Daniele Frattini,Francesco Pisani,Elvio Della Giustina |
| European Journal of Paediatric Neurology.2012;16(4)373 |
| [DOI] |
|
